the effect of plavix in post coronary artery bypass graft/coronary endarterectomy patients
Phase 2
- Conditions
- Coronary artery disease.Atherosclerotic heart disease Coronary (artery): atheroma atherosclerosis disease sclerosis
- Registration Number
- IRCT2016102730410N2
- Lead Sponsor
- Babol University of Medical Sciences, Deputy of Research & Technology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 55
Inclusion Criteria
inclusion criteria: patients undergoing Cronary artery bypass graft / coronary endarterectomy
Exclusion criteria were as follows : need to concomitant valve surgery ; history of allergic reaction to Asprin and Plavix; any systemic disease
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Cardiac enzyme : Creatine phosphokinase. Timepoint: before operation, immediatelly after operation, 24 hours after operation, 48 hours after operation. Method of measurement: serology.;Electrocardiography. Timepoint: before operation, immediatelly after operation, 24 hours after operation, 48 hours after operation. Method of measurement: Electerocardiograph.
- Secondary Outcome Measures
Name Time Method Ejection fraction. Timepoint: before operation, 3 month after operation. Method of measurement: ecocardiograph.;Wall motion score index. Timepoint: before operation, 3 month after operation. Method of measurement: ecocardiograph.